FONAR Stock (NASDAQ:FONR)


RevenueFinancialsChart

Previous Close

$15.74

52W Range

$14.05 - $24.05

50D Avg

$15.58

200D Avg

$16.97

Market Cap

$95.89M

Avg Vol (3M)

$19.30K

Beta

1.19

Div Yield

-

FONR Company Profile


FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

520

IPO Date

Oct 29, 1981

Website

FONR Performance


FONR Financial Summary


Jun 24Jun 23Jun 22
Revenue$102.88B$98.65M$97.59M
Operating Income$16.54B$14.79M$22.01M
Net Income$24.44B$9.38M$17.23M
EBITDA$16.54B$23.39M$31.40M
Basic EPS-$1.35$2.59
Diluted EPS-$1.32$2.54

Fiscal year ends in Jun 24 | Currency in USD

Peer Comparison


TickerCompany
XGNExagen Inc.
SERASera Prognostics, Inc.
ENZEnzo Biochem, Inc.
BNRBurning Rock Biotech Limited
CSTLCastle Biosciences, Inc.
BDSXBiodesix, Inc.
STIMNeuronetics, Inc.
SHCSotera Health Company